As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: Citigroup Inc., Walleye Trading LLC, Walleye Capital LLC, Creative Planning, GTS Securities LLC, Tudor Investment Corp Et Al, Wolverine Trading LLC, Jag Capital Management LLC, Royal Bank of Canada, JPMorgan Chase & Co., Laurion Capital Management LP, Schonfeld Strategic Advisors LLC, Capital Markets Trading UK LLP, Tyler Stone Wealth Management, Private Capital Management LLC, Nomura Holdings Inc., Qube Research & Technologies Ltd, Marathon Trading Investment Management LLC, PEAK6 Investments LLC, Eisler Capital UK Ltd., Eisler Capital US LLC, LPL Financial LLC, Clear Street Markets LLC, Delta Accumulation LLC, Wolverine Asset Management LLC, Maven Securities LTD, HAP Trading LLC, Group One Trading L.P., Citigroup Inc., UBS Group AG, HighTower Advisors LLC, Cutler Group LLC CA, Capula Management Ltd, US Bancorp DE, Simplex Trading LLC, XR Securities LLC, Concourse Financial Group Securities Inc., Traynor Capital Management Inc., SG Americas Securities LLC, FNY Investment Advisers LLC, National Bank of Canada FI, and Gladius Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.